Literature DB >> 3992199

Flucloxacillin-induced cholestatic liver damage.

F Bengtsson, C H Florén, I Hägerstrand, C Söderström, T Aberg.   

Abstract

Two female patients (75 and 68 yr old) developed jaundice 4 and 7 weeks respectively after treatment with flucloxacillin. Liver biopsies showed intrahepatic cholestasis. After cessation of the drug, the liver tests became normal.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3992199     DOI： 10.3109/00365548509070433

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN： 0036-5548


  8 in total

1.  Risk of cholestatic liver disease associated with flucloxacillin and flucloxacillin prescribing habits in the UK: cohort study using data from the UK General Practice Research Database.

Authors:  Stefan Russmann; James A Kaye; Susan S Jick; Hershel Jick
Journal:  Br J Clin Pharmacol       Date:  2005-07       Impact factor: 4.335

2.  Updated study on risk of cholestatic liver disease and flucloxacillin.

Authors:  Lin Li; Hershel Jick; Susan S Jick
Journal:  Br J Clin Pharmacol       Date:  2009-08       Impact factor: 4.335

3.  Granulomatous hepatitis due to combination of amoxicillin and clavulanic acid.

Authors:  C Silvain; E Fort; P Levillain; J Labat-Labourdette; M Beauchant
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

Review 4.  Flucloxacillin associated cholestatic hepatitis. An Australian and Swedish epidemic?

Authors:  B M Devereaux; D H Crawford; P Purcell; L W Powell; H P Roeser
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

5.  Synergistic Cytotoxicity from Drugs and Cytokines In Vitro as an Approach to Classify Drugs According to Their Potential to Cause Idiosyncratic Hepatotoxicity: A Proof-of-Concept Study.

Authors:  Ashley R Maiuri; Bronlyn Wassink; Jonathan D Turkus; Anna B Breier; Theresa Lansdell; Gurpreet Kaur; Sarah L Hession; Patricia E Ganey; Robert A Roth
Journal:  J Pharmacol Exp Ther       Date:  2017-07-07       Impact factor: 4.030

6.  Amoxycillin/clavulanic acid (Augmentin)-induced intrahepatic cholestasis.

Authors:  J F Dowsett; T Gillow; A Heagerty; M Radcliffe; R Toadi; I Isle; R C Russell
Journal:  Dig Dis Sci       Date:  1989-08       Impact factor: 3.199

Review 7.  Nafcillin-associated hepatotoxicity. Report of a case and review of the literature.

Authors:  M E Presti; C G Janney; B A Neuschwander-Tetri
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

8.  Cholestatic hepatitis due to antibacterial combination of amoxicillin and clavulanic acid (augmentin)

Authors:  B H Stricker; J W Van den Broek; J Keuning; W Eberhardt; H G Houben; M Johnson; A P Blok
Journal:  Dig Dis Sci       Date:  1989-10       Impact factor: 3.199
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.